10-68761162-T-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_018237.4(CCAR1):c.2076T>A(p.Asp692Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,603,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_018237.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCAR1 | NM_018237.4 | c.2076T>A | p.Asp692Glu | missense_variant | 16/25 | ENST00000265872.11 | NP_060707.2 | |
CCAR1 | NM_001282959.2 | c.2031T>A | p.Asp677Glu | missense_variant | 15/24 | NP_001269888.1 | ||
CCAR1 | NM_001282960.2 | c.2031T>A | p.Asp677Glu | missense_variant | 15/24 | NP_001269889.1 | ||
CCAR1 | NR_104262.2 | n.1965T>A | non_coding_transcript_exon_variant | 15/24 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCAR1 | ENST00000265872.11 | c.2076T>A | p.Asp692Glu | missense_variant | 16/25 | 1 | NM_018237.4 | ENSP00000265872.6 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151900Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000418 AC: 10AN: 239040Hom.: 0 AF XY: 0.0000463 AC XY: 6AN XY: 129596
GnomAD4 exome AF: 0.0000138 AC: 20AN: 1451378Hom.: 0 Cov.: 30 AF XY: 0.0000152 AC XY: 11AN XY: 722260
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152018Hom.: 0 Cov.: 29 AF XY: 0.0000269 AC XY: 2AN XY: 74326
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at